Lithuania Pharmaceuticals & Healthcare Report Q2 2018

Lithuania Pharmaceuticals & Healthcare Report Q2 2018

BMI View:

Downward pressures on reimbursement prices in particular will continue to pose major commercial issues forpharmaceutical companies operating in Lithuania, as will the small - and falling - population numbers. On the upside, opportunitiesfor value growth remain underpinned by the prevalent chronic disease profile and high levels of consumer health awareness.

BMI Industry View
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Pharmaceuticals Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Sanitas (Valeant)
Sicor Biotech (Teva)
Demographic Forecast
Demographic Outlook
Pharmaceuticals & Healthcare Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook